Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quantrx Biomedical Corp (QTXB) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Quantrx Biomedical Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 820608.
Total stock buying since 2007: $0.
Total stock sales since 2007: $695,106.
Total stock option exercises since 2007: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2007 | 0 | $0 | 993,009 | $695,106 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2007-02 | 0 | $0 | 993,009 | $695,106 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-02-06 | Levine Evan (Director) | Sale | 993,009 | .70 | 695,106 |
Insider trading activities including stock purchases, stock sales, and option exercises of QTXB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Quantrx Biomedical Corp (symbol QTXB, CIK number 820608) see the Securities and Exchange Commission (SEC) website.